BACKGROUND AND PURPOSE: MR imaging is the technique of choice for follow-up of patients with brain metastases, yet the radiologic assessment is often tedious and error-prone, especially in examinations with multiple metastases or subtle changes. This study aimed to determine whether using automated color-coding improves the radiologic assessment of brain metastases compared with conventional reading.
MATERIALS AND METHODS:One hundred twenty-one pairs of follow-up examinations of patients with brain metastases were assessed. Two radiologists determined the presence of progression, regression, mixed changes, or stable disease between the follow-up examinations and indicated subjective diagnostic certainty regarding their decisions in a conventional reading and a second reading using automated color-coding after an interval of 8 weeks.
RESULTS:The rate of correctly classified diagnoses was higher (91.3%, 221/242, versus 74.0%, 179/242, P , .01) when using automated color-coding, and the median Likert score for diagnostic certainty improved from 2 (interquartile range, 2-3) to 4 (interquartile range, 3-5) (P , .05) compared with the conventional reading. Interrater agreement was excellent (k ¼ 0.80; 95% CI, 0.71-0.89) with automated color-coding compared with a moderate agreement (k ¼ 0.46; 95% CI, 0.34-0.58) with the conventional reading approach. When considering the time required for image preprocessing, the overall average time for reading an examination was longer in the automated colorcoding approach (91.5 [SD, 23.1] seconds versus 79.4 [SD, 34.7 ] seconds, P , .001).
CONCLUSIONS:Compared with the conventional reading, automated color-coding of lesion changes in follow-up examinations of patients with brain metastases significantly increased the rate of correct diagnoses and resulted in higher diagnostic certainty.ABBREVIATION: ACC ¼ automated color-coding M etastatic disease to the human brain represents the most common intracranial tumor in adults and has substantial implications for prognosis and therapy planning. 1,2 Brain metastases occur in up to 30% of all patients in oncology, among which melanoma, breast cancer, lung cancer, and colorectal cancer are the most common underlying diseases. 3,4 MR imaging was established early